Ductal carcinoma in situ (DCIS) of the left breast: what to know

DCIS is often found on a mammogram through tiny calcium deposits rather than through a lump or pain. A breast biopsy examines sampled tissue and confirms whether the abnormal cells remain inside a duct. The report may describe the grade, the size or extent, whether the edges are clear, and hormone-receptor findings. These details help the breast team discuss whether the left breast can be treated with breast-conserving surgery or whether removal of more breast tissue is appropriate.

DCIS is different from invasive breast cancer because the cells have not been described as having grown beyond the duct. It can, however, return in the treated breast or be associated with invasive disease found elsewhere in the surgical specimen, which is why follow-up matters.

Take the pathology and imaging reports to a breast specialist. The team may recommend a lumpectomy, followed in some situations by radiotherapy, or a mastectomy when the area is extensive or appears in more than one part of the breast. Hormone therapy for cancer may be discussed when the cells carry hormone receptors. Ask how each option affects breast tissue, recovery, and future imaging.

Keep appointments for wound review and breast imaging. Report new changes on either side, and bring a list of medicines and previous breast procedures to each visit.

Contact your breast team promptly for increasing redness, swelling, warmth, drainage, fever, or worsening pain after a biopsy or operation. Seek urgent help for heavy bleeding, sudden breathlessness, chest pain, or fainting. Outside the recovery period, arrange medical assessment for a new breast or underarm lump, nipple inversion, bloody discharge, skin dimpling, or a persistent change in breast shape.

Which findings define the DCIS grade and extent in my left breast? Are the biopsy results complete, or is more tissue needed? Would lumpectomy, mastectomy, radiotherapy, or hormone therapy be suitable for me, and what would each involve? How will the right breast and the treated left breast be monitored?